Sign In
Sign Up
Two Blokes
Sarepta Stock Crashes After Death of Second Patient Receiving Its Gene Therapy
click to rate
Posted by
Two Blokes
Jun 16
- Filed in
Stock
- 6 views
A second patient receiving its experimental gene therapy Elevidys has died from liver failure, raising serious questions on the drug's outlook.
